1. The FDA approved Tymlos, a drug developed by Radius Health to treat osteoporosis in certain postmenopausal women. The injectable drug will compete against Eli Lilly’s Forteo and Amgen’s Prolia. (Reuters)
2. Physician and patients groups said the latest healthcare bill would take away protections for people with pre-existing conditions. The American Cancer Society noted that the bill would revert the U.S. to a “patchwork system” that makes these patients cover a greater share of their healthcare costs. (AP)
3. Sources told Advertising Age that WPP is cracking down on expenses, including costs associated with hiring, events, and business trips like the Cannes Lions International Festival of Creativity. (Ad Age)
4. Sanofi’s eczema treatment Dupixent has secured coverage from Express Scripts and CVS Health, a move that CEO Olivier Brandicourt described as a rare occurrence given the drug’s recent FDA approval. (Bloomberg)
5. ICYMI: Johnson & Johnson’s CIO discusses how the company is using technology to organize and better utilize data. Its consumer marketing and commercial organizations use a single tool to examine global product performance. (McKinsey)
